Anais IHMT - Saúde Global e Doenças Tropicais

58 / 114

58
Bibliografia
1. GL Jamil, A Malheiro, e F Ribeiro, Orgs., Rethinking the Conceptual Base for New
Practical Applications in InformationValue and Quality:. IGI Global, 2013.
2. C. Lynch, “Big data: How do your data grow?”, Nature, vol. 455, no 7209, p.
28–29, set. 2008.
3. S Lawrence e CL Giles,“Accessibility of information on theWeb”, Intelligence,
vol. 11, no 1, p. 32–39, abr. 2000.
4. McKinsey Global Institute,“Big Data:The Management Revolution - Harvard
Business Review”, 2011.
5. ME Porter, Competitive Strategy:Techniques for Analyzing Industries and Competi-
tors. Simon and Schuster, 2008.
6. Magalhaes, JL, Antunes, AMS, e Boechat, N, Tendências Tecnológicas no Setor
Farmacêutico: a questão das doenças tropicais negligenciadas - uma perspectiva da P,D&I no
Brasil, vol. 1. Synergia Editora.
7. BA Huberman, “Sociology of science: Big data deserve a bigger audience”,
Nature, vol. 482, no 7385, p. 308–308, fev. 2012.
8. K Nakayama, M Ito, T Hara, e S Nishio, “Wikipedia Mining for Huge Scale
Japanese AssociationThesaurus Construction”, 2008, p. 1150–1155.
9. S Moon, J Bermudez, e E ’t Hoen, “Innovation and Access to Medicines for
Neglected Populations: Could aTreaty Address a Broken Pharmaceutical R&D Sys-
tem?”, PLoS Med, vol. 9, no 5, p. e1001218, maio 2012.
10. CM Morel, SJ Serruya, GO Penna, e R Guimarães, “Co-authorship Network
Analysis: A Powerful Tool for Strategic Planning of Research, Development and
Capacity Building Programs on Neglected Diseases”, PLoS Negl.Trop. Dis., vol. 3, n o
8, p. e501, ago. 2009.
11. Quoniam, L, Competitive Intelligence 2.0. France: ISTE Ltd and JohnWiley &
Sons Inc, 2011.
12. C Dye,T Mertens, G Hirnschall,W Mpanju-Shumbusho, RD Newman, MC
Raviglione, L Savioli, e H Nakatani, “WHO and the future of disease control pro-
grammes”,The Lancet, vol. 381, no 9864, p. 413–418, fev. 2013.
13. World Health Organization, “WHO | Noncommunicable diseases”, WHO,
2011. [Online]. Available at: /
fs355/en/index.html. [Acessado: 28-fev-2013].
14. Lastres, HMM e Sarita,A,Informação e Globalização na Era do Conhecimento . Rio
de Janeiro: Editora Campus Ltda., 1999.
15. Quoniam, L, Lucien, A, Intelligence compétitive 2.0 : organisation, innovation et
territoire. France: Librairie Lavoisier, 2010.
16. JP Miller,Millenium Intelligence: Understanding and Conducting Competitive Inte-
lligence in the Digital Age. InformationToday, Inc., 2000.
17. JP Miller, Small business intelligence: People make it happen. Medford: Informa-
tionToday Inc, 2000.
18. T O’Reilly, “What isWeb 2.0: Design Patterns and Business Models for the
Next Generation of Software”, Social Science Research Network, Rochester, NY,
SSRN Scholarly Paper ID 1008839, ago. 2007.
19. Bruyère, S, Soler, R, e Quoniam, L, “Popularité et implantation des solutions
de Web Analytics comportementales en milieu francophone - eJournal of Digital
Entreprise”, EJournal Digit.Entrep., no 26, 2010.
20. Ambrosi,A, Peugeot,V, e Pimenta, D,Enjeux de mots - Regards multiculturels sur
les sociétés de l’information. France: C&F Editions, 2005.
21. R Balancieri,AB Bovo,VM Kern, RC dos S Pacheco, e RM Barcia, “An analy-
sis of scientific collaboration networks under the new technologies of information
and communication: a study in Lattes Platform”,Ciênc. Informação, vol. 34, no 1, p.
64–77, jan. 2005.
22. SM Imran, “IMPACT AND APPLICATION OF WEB 2.0 IN LIBRARIES:
A CASE STUDY OF 12 NATIONAL LIBRARIES OF THE DEVELOPED NA-
TIONS”, Braz.J.Inf.Sci., vol. 5, n o 2, jan. 2012.
23. Antunes, AMS e Magalhaes, JL, Orgs., Patenteamento e Prospecação Tecnológica
no Setor Farmacêutico. INTERCIENCIA, 2008.
24. J Lima de Magalhães, N Boechat Andrade, e A M de Souza Antunes, “Princi-
pales desafíos de la producción pública de medicamentos en Brasil y panorama del
sistema de salud”,Rev.Cuba. Salud Pública, vol. 34, no 3, p. 0–0, set. 2008.
25. Antunes,AMS e Magalhaes, JL, Orgs., Oportunidades em medicamentos genéricos:a in-
dústria farmacêutica brasileira.INTERCIENCIA,2008.
26. IMS Institute for Healthcare Informatics, “The Global Use of Medicines: outlook
through 2016”,2012.
27. Magalhaes, JL, Boechat, N, e Antunes, AMS, “An overview of the Brazilian phar-
maceutical production status”, Teknoscienze Srl - Chim.OGGIChemistryToday, vol. 26, n o 4, p.
58–59, ago. 2008.
28. GPirró,CMastroianni,eDTalia,“A framework for distributed knowledgemanage-
ment:Design and implementation”,Future Gener.Comput.Syst.,vol.26,no1,p.38–49, jan.
2010.
29. Floridi, L,Information:AVery Short Introduction.Oxford University Press,2010.
30. A L S Castro, “O valor da informação: um desafio permanente”, Rev.Ciênc.Inf.São
Paulo, vol. 3, no 3, 2002.
31. OTrelles, P Prins, M Snir, e R C Jansen, “Big data, but are we ready?”, Nat. Rev.
Genet.,vol.12, no 3, p.224–224,mar.2011.
32. J PMiller, Millenium Intelligence:Understanding and Conducting Competitive Intelligence in
the DigitalAge.InformationToday,Inc.,2000.
33. M RTrigo, L B Gouveia, L Quoniam, e E L Riccio,Using competitive intelligence as a
strategic tool in a higher education context. Nr Reading:Academic Conferences Ltd, 2007.
34. Nova Spivack,“Articles | Nova Spivack - Minding the Planet”, Nova Spivack Minding
The Planet, 2013. [Online]. Available at: .
[Acessado: 28-jan-2013].
35. Nova Spivack, “Articles | Nova Spivack - Minding the Planet”, Nova Spivack
Minding The Planet, 2013. [Online]. Available at:
articles. [Acessado: 28-jan-2013].
36. B A Huberman, “Sociology of science: Big data deserve a bigger audience”,
Nature, vol. 482, no 7385, p. 308–308, fev. 2012.
37. “Big data:The next frontier for innovation, competition, and productivity |
McKinsey Global Institute | Technology & Innovation | McKinsey & Company”,
15:19:59. [Online]. Available at:
search/technology_and_innovation/big_data_the_next_frontier_for_innovation.
[Acessado: 07-mar-2013].
38. Huyghe, F B, “Web 2.0: Influence, outils et réseaux”, Rev. Int. Intell. Econ., p.
11, 2009.
39. L S Costa, C A G Gadelha, e J Maldonado, “A perspectiva territorial da ino-
vação em saúde: a necessidade de um novo enfoque”, Rev.Saúde Pública, no ahead, p.
0–0, jan. 2012.
40. J -LVincent e M Singer, “Critical care: advances and future perspectives”, The
Lancet, vol. 376, no 9749, p. 1354–1361, out. 2010.
41. D Rouach e P Santi, “Competitive Intelligence AddsValue:: Five Intelligence
Attitudes”, Eur.Manag.J., vol. 19, n o 5, p. 552–559, out. 2001.
42. J -LVincent e M Singer, “Critical care: advances and future perspectives”, The
Lancet, vol. 376, no 9749, p. 1354–1361, out. 2010.
43. C A Gardner, T Acharya, e DYach, “Technological And Social Innovation: A
Unifying New Paradigm For Global Health”, Health Aff. (Millwood), vol. 26, n o 4, p.
1052–1061, jan. 2007.
44. J Frenk, L Chen, Z A Bhutta, J Cohen, N Crisp,T Evans, H Fineberg, P Gar-
cia,Y Ke, P Kelley, B Kistnasamy,A Meleis, D Naylor,A Pablos-Mendez, S Reddy, S
Scrimshaw, J Sepulveda, D Serwadda, e H Zurayk, “Health professionals for a new
century: transforming education to strengthen health systems in an interdependent
world”, The Lancet, vol. 376, no 9756, p. 1923–1958, dez. 2010.
45. “Project management 2.0”, Wikipedia, the free encyclopedia. 19-fev-2013.
46. E N Malamas, E G . Petrakis, M Zervakis, L Petit, e J-D Legat, “A survey on
industrial vision systems, applications and tools”, ImageVis.Comput., vol. 21, no 2, p.
171–188, fev. 2003.
47. C M Morel,T Acharya, D Broun,A Dangi, C Elias, N K Ganguly, C A Gard-
ner, R K Gupta, J Haycock, A D Heher, P J Hotez, H E Kettler, GT Keusch, A F
Krattiger, F T Kreutz, S Lall, K Lee, R Mahoney, A Martinez-Palomo, R A Mashe-
lkar, SA Matlin, MMzimba, J Oehler, R G Ridley, P Senanayake, P Singer, e M Yun,
“Health Innovation Networks to Help Developing Countries Address Neglected
Diseases”, Science , vol. 309, no 5733, p. 401–404, jul. 2005.
48. CM Morel, JR Carvalheiro, CN P Romero, EA Costa, e PM Buss, “The road
to recovery”, Nature, vol. 449, no 7159, p. 180–182, set. 2007.
Artigo Original